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Thank you for the submission of your research manuscript to EMBO reports. We have now received the full set of referee reports that is copied below.
As you will see, all three referees acknowledge the potential interest of the findings. However, referees 2 and 3 both ask to analyse EMT/MET after RAD21 overexpression, which would provide valuable mechanistic information. In addition, referee 1 points out several technical concerns and has a number of suggestions for how the study should be strengthened. In particular, referee 1 points to the incomplete or poorly described statistical evaluation of parts of the data and suggests a more extensive analysis of the expression array.
Given these constructive comments, we would like to invite you to revise your manuscript with the understanding that the all referee concerns (as detailed in their reports) must be fully addressed in a complete point-by-point response. Acceptance of the manuscript will depend on a positive outcome of a second round of review. It is EMBO reports policy to allow a single round of revision only and acceptance or rejection of the manuscript will therefore depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. Please contact us if a 3-months time frame is not sufficient for the revisions so that we can discuss the revisions further.
Supplementary/additional data: The Expanded View format, which will be displayed in the main HTML of the paper in a collapsible format, has replaced the Supplementary information. You can submit up to 5 images as Expanded View. Please follow the nomenclature Figure EV1 , Figure EV2 etc. The figure legend for these should be included in the main manuscript document file in a section called Expanded View Figure Important: All materials and methods should be included in the main manuscript file.
Regarding data quantification and statistics, can you please specify the number "n" for how many experiments were performed, the bars and error bars (e.g. SEM, SD) and the test used to calculate pvalues in the respective figure legends? This information must be provided in the figure legends. Please also include scale bars in all microscopy images.
We now strongly encourage the publication of original source data with the aim of making primary data more accessible and transparent to the reader. The source data will be published in a separate source data file online along with the accepted manuscript and will be linked to the relevant figure.
If you would like to use this opportunity, please submit the source data (for example scans of entire gels or blots, data points of graphs in an excel sheet, additional images, etc.) of your key experiments together with the revised manuscript. Please include size markers for scans of entire gels, label the scans with figure and panel number, and send one PDF file per figure or per figure panel.
I look forward to seeing a revised version of your manuscript when it is ready. Please let me know if you have questions or comments regarding the revision.
RAD21 depletion leads to upregulation of TGFB1 and ITGA5, and using ChIP an d 3C, they show that RAD21 depletion alters the local chromatin structure of these genes. One of the most interesting aspects of the article is that it provides additional evidence that RAD21 is involved in chromatin structures that repress transcription. This finding adds much needed complexity to dogma that assumes cohesin merely mediates enhancer-promoter communication. The work is valuable and should be of interest to others in the field. However, I do have quite a few concerns, in particular that the methodology was scanty and the statistical analysis absent from some of the data, making it difficult to judge whether the data are robust.
Major concerns
1. Long term 'stable' knockdown of RAD21 using lentiviral vectors (described page 6 and methods). I have some concerns about the methods. These knockdowns must be partial knockdowns, since no cell can survive without cohesin, owing to its essential role in sister chromatid cohesion during the cell cycle. I am also surprised by the length of the time period used for knockdown, i.e., 30 days.
The authors should show cell proliferation and cell cycle data to determine to what extent the cell cycle function of cohesin has been influenced by the knockdown conditions. Cell proliferation changes can also affect gene expression. è As the referee mentioned, the cohesin complex plays an important role in chromatin segregation during the cell cycle. According to the referee's comment, we checked chromatin segregation and cell cycle in the RAD21KD cells. However, similar to other studies, RAD21KD appeared to cause no problems in the cell cycle and sister chromatid cohesion in the cells (see revised Fig EV2A and EV2B). And, because RAD21KD efficiency was reduced over time in mixed RAD21KD cells, we conducted all experiments using single clones of RAD21KD cells (at least two clones per shRNA).
As a result, we had to culture the RAD21KD cells over 30 days to obtain a sufficient number of cell.
However, as we described in the original manuscript, to rule out the possibility that the gene transcription changes shown in microarray data were the results only due to the long term knockdown of RAD21, we transiently inhibited RAD21 expression, then determined the effect of RAD21 on EMT signature.
The related statements and data have been added to the revised manuscript and figure as follows:
On page 6 "RAD21 expressions decreased by approximately 75% in all cells used for knockdown of RAD21. A chromosome spread assay showed that the chromosomes in RAD21KD cells appeared to have no defective sister chromatid cohesion during mitosis and meiosis (Fig EV2A). Moreover, the 75%
reduction of RAD21 did not appear to affect cell cycle (Fig EV2B) .."
On page 7
"Furthermore, CAV1 and PRLR, which were up-regulated in both RAD21KD-MCF7 and -SNU16
cells, were induced (Fig EV2D). These results suggested that the expression changes in the
microarray data were not due to the long-term culture of the RAD21KD cells alone."
2.
More evidence is needed to support the assumption that all the differences observed are derived from epithelial versus mesenchymal biology, on the basis of analysing just a couple of cultured cell types (page 5 and figure 1 ). Convincing gene expression signatures from the array data (see point 4 below) would persuade the reader that differences are not purely due to inherent differences between cell lines. For example, some lines are ER positive (MCF7, T47D) while others are triple negative (MDM-MB-453) and are therefore intrinsically different. à Thank you for the interesting question. Yes, as you are aware, MCF7 and T47D cell lines, characterized as epithelial cancer, are ER positive cells in luminal A type (ER+/PR+/HER2-).
However, MDA-MB-453, characterized as epithelial like cancer, is rather HER2 positive (ER-/PR-/ HER2+). Moreover, HCC70, classified as an epithelial cancer, is also triple negative cancer (ER-/PR-/HER2-). And three cell lines, which are characterized as mesenchymal like cancer (MDA-MB-231, HCC1143, and MDA-MB-157) are triple negative. Additionally, we further used gastric cancer cell lines (SNU16 and SNU620) for our study to rule out any possibilities of the result from tissuespecific characteristics.
So, we figured that these suggest that the different subtypes of breast cancer are not quite relevant to the outcome of the study.
On page 6
"In addition, to rule out the possibility of breast cancer specific properties, we stably depleted
RAD21 using shRNAs in epithelial gastric cancer cells SNU16 and SNU620"
3 Statistical tests -in all examples, please name the statistical test used to provide P values in each case where P values are given. Some graphs indicated as significant, e.g., in EV2, do not appear to be so on the basis of the error bars (there is overlap of error bars). è We apologize for the oversight. We calculated the statistical significance of all results using an unpaired t-test (student's t-test), and p-values < 0.05 were considered to be statistically significant. We have described this in detail in the revised manuscript.
4. Affymetrix array data. There are no data analysis methods or statistical evaluation provided with the array data, or information about other dysregulated genes (other than genes of interest). Has the data been deposited in GEO or similar? The desired EMT genes have simply been cherry-picked. What other gene expression information is present in the array data? è In the original figure 2D , the graph simply shows the up-regulated genes (fold change > 2) in RAD21KD -MCF7 cells (upper graph) and -SNU16 cells (lower graph) compared to its counterpart. The graphs simply show the order of the TGFB1 and ITGA5 genes on the list. According to the referee's suggestion, we have listed the genes up-regulated by RAD21KD in MCF7 and SNU16 cells in the revised TGFB1, ITGA5, CAV1, PRLR, LGALS1, SEMA3C, WLS, FERMT1, and TGFB1I1 gene."
Can this gene expression information be used to determine statistically significant gene expression signatures that result from long-term RAD21 depletion? è Yes, this is a very important question for the stable knockdown of some genes. We were also concerned with this issue and therefore decided to transiently knockdown the cell with RAD21-specific siRNAs. As shown in the original Fig EV2A, consistent with the transcriptome data shown in the original Figure 2E , we observed the induction of TGFB1 and ITGA5 mRNA expression after RAD21-sepcific siRNA transfection in epithelial cells. However, as the reviewer suggested, we conducted qRT-PCR using the transient knockdown samples used in the original Figure 2E with other genes on the up-regulated gene list to confirm the microarray data. We found that the results were consistent with the transcriptome data. We have added these data to Fig EV2D, Can the data be used to confirm that cell proliferation is intact and that the cells are not simply stressed? è As mentioned above, we verified that the RAD21-depleted cells had no problem with the cell cycle based on the results of FACS analysis and chromosome spread assay, suggesting that the cells were intact despite the RAD21 depletion ( Figs EV2A-B) . Furthermore, Functional annotation cluster analysis using the microarray data for the RAD21KD-MCF7 and -SNU16 genes usually involved in cellular response to stress were not included in the statistically significant enrichment cluster. The related functional annotation cluster analyses have been added to the revised Table EV3 and EV4. Taken together, these data suggest that approximately 75% depletion of RAD21 in the cells does not affect cell proliferation.
How does the array data compare with the many other datasets that are out there, particularly in MCF7 cells for which much data is available (e.g.,http://www.ncbi.nlm.nih.gov/pubmed/25542856 http://www.ncbi.nlm.nih.gov/pubmed/24752895)? è We thank the referee for the question. According to the suggestion from the referee, we had tried to compare the data suggested from the referee; GSE59908 and GSE25710, however, the platforms used in the studies were not same with ours. So, we compared our microarray data of MCF7 cells (affymetrix human gene st 2.0 platform; GPL21563) with other group (GSM1142895).
From the comparison result, we have verified that MCF7, which was used in our study, shows a similar expression pattern with the MCF7 cells used in other study group.
The correlation data has been shown in the Data only for Referee Fig 1E   5 The authors state on page 8: "Given these data, we wondered if TGFB1 and ITGA5 expression induced by RAD21-depletion directly initiated the EMT process, or if the expression of one or both was simply a result of the acquisition of EMT properties via RAD21 depletion in epithelial cancer cells. We therefore knocked down either TGFB1 or ITGA5 in RAD21KD epithelial cancer cells with elevated TGFB1 and ITGA5 expression (Figs 3F and 3G, and Figs EV3C and EV3D)." It is not clear how the experiment presented in Figure 3 answers the question. è The results of our study showed that TGFB1 and ITGA5 were notably induced after RAD21 depletion in epithelial breast and gastric cancer cell lines. Simultaneously, we found that the induced cells underwent a morphological change, developing mesenchymal-like features with transcription induction of EMT markers, such as VIM, ZEB1/2, N-cadherin and TWIST. Therefore, we speculated that the TGFB1 and ITGA5 induced by RAD21 knockdown might be drivers to induce epithelial to mesenchymal transition in epithelial cancer cells. To confirm this speculation, we had to demonstrate the induction of TGFB1 and ITGA5 were drivers for EMT, and not results occurring after EMT. Because we thought it might effectively and clearly show the role of TGFB1 and ITGA5 in the EMT-induced cells by RAD21-depletion, we attempt to reversely knockdown each TGFB1 and ITGA5 gene in both genes -induced in cells by RAD21 knockdown. If the genes were drivers or important factors for EMT, there would be a reverse result showing MET gene expression signatures after depletion of the genes in the genes-induced cells by RAD21 depletion. As shown in original Figure 3F and 3G and EV3C and EV3D, while no reverse morphological change from mesenchymal into epithelial cells were observed, some EMT markers were notably reduced under TGFB1 and ITGA5 knockdown in EMT-induced epithelial cells by RAD21-Knockdown.
The experiment shows that knocking down TGFB1 or ITGA5 are mutually antagonistic and allow mesenchymal markers to be upregulated, but the data do not allow interpretation of whether TGFB1 or ITGA5 are directly or indirectly regulated by RAD21 or EMT. Since both TGFB1 and ITGA5 were already shown to be involved in EMT, this experiment does not add much to the manuscript. è We agree with the referee's opinion that the data is not sufficient to convince the referee and readers of whether the genes were directly regulated by RAD21 or not. Our results focused on the transcriptional up-regulation of TGFB1 and ITGA5 genes by modulation of cohesin-mediated threedimensional chromatin structures, thereby leading to EMT. We wanted to determine whether the induced TGFB1 and ITGA5 genes that were observed in both RAD21KD-MCF7 and -SNU16 cells affected the EMT signature in the cells or what functions the genes did in the RAD21KD cells. As the referee was aware, TGFB1 and ITGA5 are well known factors responsible for EMT. However, as the genes have multi-functions, we needed to determine whether they were associated with the EMT signature. We expected that, if the up-regulated ITGA5 and ITGA5 genes were important to the EMT process, EMT-related genes would be reduced when they were reversely knocked-down again. We confirmed that the genes were directly regulated by the Cohein molecule using a ChIP assay that showed the RAD21 molecule bound directly to TGFB1 and ITGA5 genes. 
')."
It is not a good idea to set the control cells to '1.0' for the gene of interest, since its expression could vary across conditions anyway, and it would be helpful to see what variation there is. è We agree with the referee's comment and thank you for this suggestion. Although we attempted to show the relative expression levels of each gene against a reference gene (18s rRNA) in a graph as the referee mentioned, the expression values of the individual genes varied from 1.2E-07 to 3.5E-03 (normalized against 18s expression). For example, in the case of CDH1 expression, the level was so high that other expressions appeared to be unchanged relative to the controls. However, according to the referee's suggestion, the expression change of each gene, normalized by 18S expression, have been shown in Data only for referee figure 1D .
Primer sequences should be provided in the manuscript, not 'on request'.
è We agree and have listed all primers used in this study in revised Table EV5. 7 Cell morphology ( Fig 3A) . Is this really EMT or could the cells just be stressed? See point 4.
è We thank the referee for this interesting question. There are several reasons in vitro cancer cell lines undergo morphological changes. After cell lines are cultured continuously for a long period, the cells could undergo EMT-like morphological changes. To rule out this possibility, we cultured the control cells (indicated as "shCont") under the same culture condition and culture period as RAD21KD cells (indicated as "shR#1 or shR#2"). We found that the EMT-like morphological changes only occurred in RAD21KD-epithelial cancer cells including RAD21KD-MCF7 and -SNU16 cells.
è As the referee mentioned, another reason could be the cellular responses to some stresses. To verify whether the morphological changes occurring during RAD21-depletion in epithelial cancer cells are due to cellular responses to stresses, we evaluated which genes were up-regulated by RAD21-knockdown (revised Table EV3 and EV4). As mentioned above, the functional annotation cluster data for the up-regulated gene set showed that most genes were involved in cell motion, cellular structure, and cell migration. Although genes related to cellular response to stresses such as HIPK2, EDN1, and ZNF675 were included in the up-regulated gene set, they were not statistically significant (P-value > 0.5). Accordingly, we can rule out the possibility that the EMT-like morphological change is due to the response to stress.
è We apologize for not providing a clear description of the methodology used for the ChIP assay we conducted. We have added more detail to our description in the Material and Methods section of the revised manuscript as follows:
On Page 20
"ChIP assays were performed as previously described. 
and RAD21KD-MCF7 or -SNU16 cells (Figs 4B-C and EV4B-C). In both shCont-MCF7 and -
SNU16 cells, low enrichment of Pol II, Ser2P, AcH3, and H3K9ac was detected on both genes."
9 3C assay. Statistical significance should be provided, along with the statistical test used. A more complete description of the 3C methods should be provided; since several papers are referenced, it is not clear which was followed for which aspect. For e.g., which enzymes were used for which genes? è As the referee pointed out, we calculated the statistical significances of the 3C graph in Figure  4D and 4E and described it in the figure legend section of the revised manuscript. We have also described the 3C methods in details and the enzymes used for the 3C assay in the materials and methods section of the revised manuscript. The added or revised sentences are marked in blue in the revised manuscript.
It is not clear why the ERCC3 gene was used as a 3C control, please describe the basis for this control.
è We are sorry that this part was not clear in the original manuscript. Many other studies have utilized the ERCC3 gene as a 3C control to correct for differences in crosslinking and digestion efficiencies between samples. There are several reasons to use this gene, including that it forms a three-dimensional chromatin structure in the nucleus and is expressed ubiquitously in various cells [4] [5] [6] [7] . Although the calreticulin (CalR) gene is also well known 3C assay normalization control [8] , we thought that ERCC3 gene was the best normalization control for our 3C assay condition because of its sequence which is properly fragmented by BamH1 or XbaI. We have described the reasons we used the ERCC3 gene as a normalization control for the 3C assay in the Materials and Methods section of the revised manuscript as follows:
On Page 22
"We tested ERCC3 as a control gene that is ubiquitously expressed in various cells and formed in
the gene specific three-dimensional chromatin structure."
In the accompanying models, why is a double loop shown for ITGA5 when only a single interaction with the anchor is present? The cartoon models are not very helpful for interpreting the data. è As shown in the original Figure 4D and Figure 4E , as well as EV4B and EV4C, we verified that cohesin complex regulated both TGFB1 and ITGA5 gene transcriptions through the formation of gene-specific three dimensional chromatin structures on the genes. Comparing the 3C data between the original Figure 4E and EV4C enabled development of the proposed model of the ITGA5 genespecific chromosome structure. Figure 4E clearly shows the intra-chromosomal interaction between the transcription start site (TSS) and the upstream portion of the gene (an anchor indicated by the black bar). Interestingly, in the original figure EV4, another anchor located on the 3' end of the gene strongly interacts with an area near the TSS. Based on these data, we came up with the proposed model of the cohesin-regulated three-dimensional intrachromosomal interaction, as the cartoon showing a double loop of the gene. Each of the sites (indicated by the anchors; the upstream and 3' end of the gene) on which strong enrichment by Rad21 was shown (shown in the original figure 4A, ITGA5 graphs) appears to more strongly interact with the gene promoter rather than each other.
In EV4, why were these anchors chosen, since little RAD21 binds there? è We actually considered this issue. The ChIP assay data showin in the original Figure 4A and EV4 revealed that RAD21 strongly bound at the upstream and the 3' end of the ITGA5 gene (the anchors are shown in the original Figure 4A and EV4A for both RAD21KD-MCF7 and -SNU16 cells. However, in the case of the TGFB1 gene, the pattern of RAD21 binding on the gene was shown to be different in MCF7 and SNU16 cells (original Figure 4A ). While strong binding of RAD21 was observed at the gene promoter (Amplicon 5,7, and 6) in MCF7 cells, those in SNU16 cells were detected at the 3' end of the gene and the gene promoter (amplicon 1, 5, 7, and 6, respectively). To ensure the chromosomal interaction of the gene, we had to determine the interaction frequency from other anchors. Based on the results of the ChIP assay for RAD21 in SNU16 cells (original Figure 4A ), we selected the site shown in the original figure EV4B as an anchor.
If the maximum crosslinking frequency is set at 1, why are the values on the y axes of 3C graphs so high? è We apologize for our mistake. In general for the 3C assay, the interaction frequency (Y-axis) is re-calculated by dividing each value by the highest one to set to '1' [9] as mentioned in the original figure legend. However, we made a mistake in the calculation process. So, in the revised version of the figure, the Y-axis for the 3C assay graph has been amended.
10. The authors suggest that cohesin depletion leads to metastasis (via upregulation of EMT genes), but the only experiment in the manuscript that addresses metastatic potential is the wound-healing assay in MCF7 cells (Fig 3E) . Furthermore, RAD21 depletion appears to cause a cell shape change to a more flattened cell ( Fig  3A) , so it is not clear that wound closure happens via migration as opposed to cell spreading, and the image in 3E is not high enough resolution to distinguish between these possibilities.
è We thank the referee for their helpful comment. We have amended the images to be clear in the revised figures.
Therefore, additional evidence is needed to support the metastasis conclusion. I suggest that for the CSCs isolated from MDA-MB-453 cultured cells, a trans-well migration assay (or similar) should be conducted to determine if these cells gain migration potential as a result of RAD21 depletion. è Thank you for this suggestion. According to the referee's comment, we conducted a transwell migration assay using CSCL and RAD21KD-SNU16 cells. Among them, only the transwell migration assay for SNU16 cells, expressing shContol and shRAD21, failed. Even though RAD21KD-SNU16 cells seemed to obtain several migratory features, the cells did not move through the transwell membrane. We thought this was because of their strong non-adherent and noninvasive characteristics. We observed that the MDA-MB-453 CSLC cells migrated well through the fiber-transmembrane compared to its counterparts. We have added these results to the revised manuscript and figure 5C as follows: 11. RAD21 is just one subunit of cohesin, and its level of expression will depend on the level of cell proliferation and on the amplification status of 8q24 (which usually includes MYC, but since the RAD21 gene is 1 Mb from MYC, it will sometimes be included). Therefore it is important not to generalise that expression levels of RAD21 are tightly correlated with a mesenchymal or epithelial phenotype, when factors such as proliferation and copy number variation could influence expression levels. Determining the amplification/copy number status of RAD21 and the expression levels of other cohesin subunits could be used to clarify this point (could be queried through TCGA data). è We thank the referee for this helpful comment. This question is very interesting and important to determine whether the different expression of RAD21 in epithelial and mesenchymal cancer cells depends on its gene copy number or its transcriptional activity (or level). As the referee mentioned, the RAD21 gene is located on chr8 (near the c-MYC gene), and it is possible that RAD21 would be amplified and accompanied by the c-MYC amplification. We have published a paper showing that c-MYC was amplified with adjacent genes formed as a double minute (extra-chromosome) [10] . According to the referee's comment, we conducted the CNV assay for RAD21 and c-MYC (revised Fig EV1C, and Data only for referee Fig 1A) , and checked the expression level of other cohesin subunits in the mesenchymal and epithelial breast cancer cell lines, SMC1A and STAG2 (SA2) (revised Fig EV1A and EV1B ). Two out of three epithelial cell lines and one out of three mesenchymal cell lines had more than three copies of the RAD21 gene, indicating that it would be difficult to say that the RAD21 protein levels are correlated with gene copy number (revised Fig  EV1C) . As well as, we found that the level of RAD21 gene copy number was not correlated with the c-MYC copy number (Data only for referee Fig 1A) . Moreover, no significant difference in the expression of other cohesin subunits was observed between epithelial and mesenchymal cell lines (Fig EV1A and EV1B ). This has been described in the revised manuscript as follows: (Fig EV1C) ."
Minor comments
1. Some of the English could be clarified with through proof-reading, for example "transcriptional expressions", "cellular transition into mesenchymal feature" (in abstract). Some spelling mistakes are evident, e.g., "intergrins", "Immunofluorecsence analysis" (p 16) è The entire manuscript has been professionally edited by a native English speaker. 4. Figure 1 . Blots in 1A, D should be quantified. Fig 1B, closer views of the cells could be provided for MCF7, as it is hard to see the relative location of RAD21 and E-cad. I am surprised by such low levels of RAD21 in HCC1143. è As the referee recommended, we have added data showing quantified blots for the original Figure 1A and 1D into the revised Fig 1A and Fig EV1D, respectively, and provided enlarged IFA images of the original Figure 1B . RAD21 is only located in the nucleus for both MCF7 and HCC1143 cells, but E-cadherin is expressed in the cytoplasm as well as the nucleus.
5. Figure 2 . In F, 18s RNA is not an appropriate reference, as it is way more abundant than the RNAs being compared to it. è As the referee mentioned, desirable reference gene is known to show a similar threshold cycle with genes of interest (e.g. basic metabolism genes which is also called housekeeping genes) [13] . Nevertheless, it is well known that 18s RNA, which has abundant expression, is used as a reference gene because of its stability under various conditions and in different cell lines [14] . Multiple reference genes are required for accurate normalization. Therefore, we agree that it is necessary to confirm the gene expression level based on normalization to other reference genes. Therefore, we repeated the experiment shown in the original Figure 2F using actin as a reference. As shown in Data only for referee Fig 1B, there was no significant change compared to the result of the original Figure 2F .
6. Figure 3 . Closer views, or zooms of the cells in 'A' would be better for viewing morphology. è The image in the original Figure 3A has been enlarged in the revised figure.
In B and C, what are the arrows pointing to? Not mentioned in legend. è In the original figure, the white arrows indicated the fibroblast-like shape of the cells. However, the arrows have been removed from the revised version of the figure.
Immunofluorescence with b-catenin would be helpful to determine Wnt signalling status, (ie nuclear localization indicating active Wnt signalling). è We thank the referee for their helpful comment. Yes, based on the IFA assay for beta-catenin (the original figure 3C ), RAD21-depletion in epithelial-like cancer cells led to not only morphological changes into mesenchymal-like shape (front-to-back leading polarity) but also an accumulation of beta-catenin molecule into the nucleus of the cells. This is commonly used for a represent molecular marker of EMT. As the referee is aware, the observation of nuclear beta-catenin is followed by activation of Wnt-signaling. This nuclear beta-catenin by activated Wnt signaling can induce EMT by activating transcription of EMT-related genes. According to a recent study [15] , it is known that TGF-beta activates canonical Wnt signaling. Based on these findings, we were able to speculate that the induction of TGFB1 by RAD21-depletion might cause canonical Wnt signaling activation, which could lead to the accumulation of b-catenin into the nucleus. Consequently, it would activate EMT. We have added the following text describing this to the revised manuscript: In D, some of the blot images are very pixellated. è We have improved the resolution of western blot images in the revised Figure 3D F, G, not correct to set genes to 1.0 in control cells. What happens to these genes in a non-RAD21-depleted situation? è This is an interesting question. In this study, we transiently and stably depleted RAD21 in epithelial cells (MCF7, T47D, and SNU16, SNU620) expressing high levels of RAD21 molecule. The expression of ITGA5 and TGFB1 genes is usually low in these cells. However, under RAD21 knockdown conditions, both genes were significantly upregulated in these cells, causing the induction of other EMT-related genes. Therefore, we attempted to deplete each ITGA5 and TGFB1 gene reversely in these RAD21KD cells expressing high level of the genes to determine the effect of the up-regulated genes on the cells. Although the expression of both TGFB1 and ITGA5 was low in the non-RAD21KD cells, according to the referee's comment, we transiently knocked-down ITGA5 (siITGA5#2) and TGFB1 (siTGFB1#4) in non-RAD21KD-MCF7 cells. The results showed that the EMT-related genes used in this study, including VIM, ZEB1, CDH2, SNAI2, and TWIST, were slightly up-regulated when TGFB1 and ITGA5 were depleted (See "Data only for referee Fig 1C" ). These results are similar to those observed for RAD21KD-MCF7 cells. Unlike in RAD21KD-MCF7 cells (See the revised Fig. 3G , and 3H), when each gene was knocked down the non-RAD21KD-MCF7 cells did not appear to crosstalk with each other. Specifically, when TGFB1 was knockeddown, ITGA5 expression was reduced, and vice versa. These results indicate that the function of TGFB1 and ITGA5 genes in MCF7 epithelial cells is similar to that in RAD21KD-MCF7 cells.
7. Figure 4 , 5. Not essential, but it would be nice to see the binding pattern of the elongating version of Pol II. Is the currently used antibody a Pan-Pol II? è Yes, in the original results, we used Pan-Pol II specific antibody. However, we agree with your suggestion, therefore, we conducted a ChIP assay using Serine-2 phosphorylation at the CTD of RNA Polymerase II-(Ser2P) specific antibody to further determine the difference in transcriptional elongation activity depending on the RAD21 binding. Consistent with the enrichment of Pol 2 shown in the original figure 4A , Ser2P binding on the gene also notably increased under RAD21KD condition (revised Fig EV4B) . We have added text describing this to the revised manuscript and figures.
8. Model, Fig 6. What does the yellow sphere in the cell at top represent? A repressive cluster? è Yes, in the original figure, the yellow sphere in the Figure 6 was meant to indicate a kind of repressive cluster. However, we thought that the figure would confuse the reviewer and the readers because the proposed model showing the genes, which were gathered by the yellow repressive cluster, has not yet been proved. It was just our speculation. So, we carefully decided to amend the figure and the figure has been changed in the revised version of figure 6E.
There is a typo at the bottom "High trasncriptional activity" è Thank you for your comment. We have corrected the typo in the revised figure.
Referee #2
These authors present evidence that cohesin mediated chromatin organization initiates and coordinates the epithelial to mesenchymal transition (EMT) by activating genes important for EMT. Specifically, they reduce the cohesin component Rad21 in epithelial cancer cells and show increases in transcription of TGFB1 and ITGA5 coordinated with a release of chromatin looping in the genes. Upregulation of these genes leads to EMT. The same outcome occurs in a cancer stem cell model. The results suggest that cohesin influences a reversible transition between epithelial and mesenchymal states by influencing chromosomal architecture. These findings are of broad interest and, furthermore, may suggest a means to control tumor metastases through manipulation of cohesin levels. Comments 1. EMT is known to be reversible. To support a direct role of cohesin in EMT, it would be nice to see that authors perform a reverse experiment and overexpress Rad21 in basal-like cell lines ( Figure  1A) . è We thank the referee for this helpful input. We agree with the referee's suggestion that the overexpression of RAD21 to confirm the reversible effect of chromosomal conformation changes on TGFB1 and ITGA5 gene transcriptions would be useful to confirm our results. Although we attempted to overexpress RAD21 in RAD21KD-epithelial cells (MCF7 and SNU16), the cells could not be maintained over two passages for unknown reasons. Therefore, we tried to overexpress RAD21 in the mesenchymal cell lines: HCC1143 and MDA-MB-231, as well as the MDA-MB-453 cancer stem-like cells (CSLCs). Because HCC1143 cells were shown to have a very low level of transfection efficiency, we excluded HCC1143 cells from the overexpression experiment. Although the level of overexpressed RAD21 was not as high as we expected, the results showed that the overexpression of RAD21 in mesenchymal cell lines with a low level of RAD21 clearly led to the reduction of both TGFB1 and ITGA5 expression that was accompanied with a reduction of expression of other EMT-related genes. Using a ChIP assay, we also verified the increased RAD21 binding to the genes, thereby slightly inducing the gene-specific chromatin interactions in RAD21-overexpresed mesenchymal cells. However, we were not able to observe significant morphological changes in the MET-like features. These results have been added to the revised version of Fig 6A-D è We apologize that this was not clear in the original manuscript. Based on our results and many other chromatin regulation studies [16] , we speculated that TGFB1 and ITGA5 gene-specific chromatin loop structures-mediated by cohesin complex might regulate its gene transcriptional activity via modulation of the transcriptional environment. The strong intrachromosomal interactions between genes appeared to significantly recruit transcription factors such as RNA polymerase and to enhance the enrichment of active histone modifications, AcH3 and H3K9ac (revised figure 4 and EV4, and figure 5D and 5E) to the genes. Conversely, when the cohesin bound to the genes was detached by RAD21-depletion, the three-dimensional loops were released, leading to reduction of transcriptional factor bindings and active histone marks on the genes. We agreed with your suggestion below that it would be great to show the de-regulation of the gene expression through the endogenous chromatin loop deletion using a "CRISPR-Cas9 system". Unfortunately, we tried to do this several times unsuccessfully (see our response to the next question). However, we clearly found the opposite results in RAD21KD-epithelial cancer cells (explained above). Taken together, these findings suggest that the gene-specific chromatin structures mediated by cohesin complex play an important role in the gene regulation. This has been described in greater detail in the revised manuscript.
è We conducted a ChIP assay to determine the level of a repressive histone marker H3K27me3 on the TGFB1 and ITGA5 gene in the Control-vs RAD21KD-epithelial cancer cells (Data only for Referee Figure 2C ). Unexpectedly, although strong recruitment of Pol2, increased Ser2P, and active histone marks on the genes were found, we observed increased binding of it to the genes rather than a loss of enrichment. However, since the data did not appear to be correlated with the level of upregulated gene expression, we thought it would confuse some readers. We speculated that the genes existed with bimodal distributions (both active and inactive histone modifications).
If this is the case, authors should consider deleting these elements by genome editing techniques to confirm their role in regulation of targeted gene expression. è We thank the referee for this helpful comment. We also considered it important to address this issue. We thought that it would be nice if we could completely abrogate the cohesin-mediated highorder chromatin structure on TGFB1 and ITGA5 by using CRISPR-Cas9 genome editing technology; however, when we attempted to do this we failed to obtain effective deleting of the genes in MCF7 cells (epithelial cells) ex vivo. Nevertheless, as we mentioned above, we clearly found that down-regulation of cohesin, which is important to formation of three-dimensional chromatin structure, disrupts the gene-specific chromatin structure, thereby enhancing the recruitment of active transcriptional marks and machinery. Additionally, we found that the overexpression of RAD21 in mesenchymal cells slightly upregulated the gene-specific chromatin interactions. This led to decreasing active transcriptional markers on the genes, resulting in a reduction of gene transcription.
3. Given the role of cohesin in insulator and enhancer function, it sounds counterintuitive that cohesin depletion caused activation of gene expression. The authors should provide more extensive discussion about how their case is different from previously described activating role of cohesin. è We thank the referee for the comment and apologize that this was not clearly addressed in the original manuscript. Cohesin plays multiple roles in gene transcription. It not only activates but also inhibits gene transcription through the formation of inter-or intra-chromosomal interactions. As mentioned by the referee, cohesin can bind to enhance genes, thereby stabilizing long-range enhancer-promoter interactions [17, 18] . In addition, it binds to insulator of genes to prevent the spread of repressive transcription from near transcriptional environment. Indeed, many other studies have shown that the major role of cohesin in chromatin architecture for gene transcriptional regulation is to activate gene transcription (e.g., β-globin, interferon γ locus, and H19-IGF2). Therefore, disruption of the cohesin molecule leads to reduced gene transcription. Conversely, some other studies have shown that the perturbation of cohesin complex via depletion of its subunits causes up-regulation of gene transcriptions [19] . For example, abrogation of chromatin loops on the H19-IGF2 locus by knockdown of cohesin activates IGF2 mRNA expression. Consistent with our results, several studies have revealed that knockdown of RAD21 leads to significant recruitment of Ser2-Pol2, allowing gene transcription to be activated. Taken together, inactivated TGFB1 and ITGA5 genes are maintained by the cohesin-mediated chromatin loop structure in epithelial cells and when the chromatin interactions are released by a loss of cohesin complex binding, the genes are transcriptionally activated via active recruitment of transcriptional machinery to the gene promoter. Text describing this has been added to the discussion section of the revised manuscript as follows:
On Page 16
"According to recent studies, cohesin can bind to enhancer of genes, thereby stabilizing lon g-range enhancer-promoter interactions. Moreover, it binds to insulator of genes to prevent the spre ad of repressive transcription from near the transcriptional environment. Similarly, many other studi es have shown that the major role of cohesin in chromatin architecture for gene transcriptional regu lation is to activate the gene transcription (e.g. β-globin, interferon γ locus, and H19-IGF2). Howev er, other studies have shown that the perturbation of cohesin complex causes up-regulation of gene t ranscriptions. Consistent with our results, several studies have shown that knockdown of RAD21 lea ds to significant recruitment of Ser2-Pol2, causing the activation of gene transcription. Taken togeth er, these findings demonstrate that inactivated TGFB1 and ITGA5 genes are maintained by the cohe
sin-mediated chromatin loop structure in epithelial cells, and release of the chromatin interactions b y a loss of cohesin complex binding results in the genes becoming transcriptionally activated via act ive recruitment of transcriptional machineries to the gene promoter and formation of an active trans criptional environment."
Also authors should consider evidence of functional interaction between cohesin and polycomb group proteins in gene repression in Drosophila (PMID: 23818863). è We thank the referee for this interesting comment. According to many studies, some types of chromatin loops, which play important roles in transcriptional regulations, have been elucidated [20] : namely, 1) enhancer-promoter loops, 2) insulator-mediated loops, 3) intra-genic loops, and 4) polycomb-mediated loops. It is well known that polycomb groups (PcG) accompanying cohesin complexes repress many genes through physical interactions with the gene that result in silencing via various inactive histone modifications. As the referee suggested, we attempted to determine whether TGFB1 and ITGA5 genes regulated by cohesin-mediated chromatin structures are affected by or directly associated with the polycomb groups, SUZ12 and EZH2, in RAD21KD-MCF7 and -SNU16 cells (Data only for referee Figure 2A and 2B). Using a ChIP assay, we verified that the enrichment level of SUZ12 and EZH2 on the TGFB1 and ITGA5 genes showed tissue specific patterns. In the SNU16 cell lines, SUZ12 and EZH2 directly bound to both genes, which were expressed at low levels, and the binding was notably decreased under RAD21KD which caused induction of gene expression. These findings suggest that this would be more relevant to the repressive gene regulation. On the contrary to this, in MCF7 cells the polycomb groups might not be associated with the repressive transcriptions of TGFB1 and ITGA5 genes. The polycomb groups are either not bound to the genes (SUZ12 on TGFB1), or correlated with the gene transcription activity (EZH2 on TGFB1 and ITGA5, and SUZ12 on ITGA5). These findings suggested that polycomb groups might not be associated with the repressive gene transcription of the genes in any cancer cell lines.
Minor points:
1. Conclusions about changes in protein abundance based on western blotting should be supporting by measuring of relative band intensity (related to figures 1A, 2B and 3D). è Thank you for this suggestion. We have added the graph showing the Western blot intensity in Figs EV1D, EV2C, and EV3C.
2. Page 6, "As shown in figure 2C , ... although the expression of all EMT markers was not induced in both cell types". SNU16 data should be added to figure 2C . è Yes, we have already added the data for SNU16 cell lines to the original Figure 2C . However, we thought that the figure provided unclear information to some readers. Therefore, we have enlarged the font of the letters on Fig 2C in the revised figure. 3. Which restriction enzyme was used in the 3C assay? Authors should add details about primer efficiency normalization (including BAC clone catalog numbers if used) to corresponding Material and Method section. è As the referee recommended, we have listed the primer and described the BAC clone used in 3C assay in Table EV5 and the Materials and Methods section in the revised manuscript.
4. AcH3 ChIP data should be normalized by total H3 abundance. è As indicated by the referee, in the ChIP assay the enrichment of AcH3 on genes should be normalized to that of the total H3. However, we neglected to do so in the original study. Therefore, we conducted a ChIP assay using H3 and AcH3-specific antibodies in the same sample used in the original ChIP assay. This has been described in the figure legends of the revised manuscript and the figures have been amended. 5 . Sequence of all primers used in the paper should be listed in the manuscript. è We have listed the all sequence of the primers used in our experiment in the revised Table EV5 and added the following text describing this to the Materials and Methods section:
"The PCR primers used for the ChIP and qPCR assays are presented in Table EV5 ."
Referee #3
In the current manuscript of Yun et al. the authors analyzed the role of the cohesion complex component RAD21 in regulation of EMT-related genes and its implication in EMT-MET processes. Based on a correlation between RAD21 expression and EMT status of various tumor cell lines, the authors identified that EMT was induced in epithelial cancer cells upon knockdown of RAD21. Microarray anaylsis revealed two genes, TGFB1 and ITGA5 that are consistently upregulated in RAD21 knockdown cells. The authors demonstrate that these genes are crucial for the RAD21-dependent dynamic EMT-MET processes and provide evidence that deregulation of RAD21 has also implications in the clinic.
This study is of particular interest as it shows for the first time how cohesins act as tumor suppressors and how RAD21 deregulation is involved in metastasis by promoting EMT. This helps to better understand the process of EMT and will be of interest to many researchers. The study is performed thoroughly and with high skill and results are presented properly. However, before acceptance for publication, I have some concerns that need to be solved first:
1. The authors exclusively used a knockdown approach to induce EMT. Does overexpression of RAD21 in mesenchymal cancer cells induce MET? Maybe RAD21 is rather acting to prevent EMT in cells that are already primed for EMT, but loss of RAD21 on its own cannot induce EMT. So, it would provide valuable information, if mesenchymal cells are forced to express more RAD21 and see whether they undergo MET or not. è As the referee recommended, we overexpressed the RAD21 molecule in mesenchymal cancer cell lines with low levels of RAD21 expression, HCC1143 and MDA-MB-231, as well as in MDA-MB-453 cancer stem-like cells (CSCs). Since HCC1143 cells were shown to have a very low transfection efficiency, we excluded these cells from the overexpression experiment. Although the level of overexpressed RAD21 was not as high as we expected, the results showed that the overexpression of RAD21 in mesenchymal cell lines with a low level of RAD21 clearly led to reduced TGFB1 and ITGA5 expression. Moreover, this reduced expression was accompanied by reductions in the expression of other EMT-related gene. Taken together, these findings suggest that the RAD21-overexpressed mesenchymal cancer cells showed an MET gene expression signature. Using a ChIP assay, we also verified the increased RAD21 binding on the genes, thereby slightly inducing the gene-specific chromatin interactions in RAD21-overexpresed mesenchymal cells. However, we were not able to observe significant morphological changes in MET-like features. The related results have been added to the revised manuscript in Fig 6A-D Figs 6A-B) Fig. 5 : In line with the discussion about the fact that CSCs are generated from non-CSCs and my previous comment: The role of RAD21 in EMT should be reflected in the ability to convert P and CSCL by manipulating RAD21 by overexpression or knockdown. è We thank the referee for this interesting input. To answer this question, we overexpressed RAD21 in CSLC cells having a low level of RAD21 expression. As mentioned above, we found that transient overexpression of RAD21 in CSLC cells induced direct binding of RAD21 on the TGFB1 and ITGA5, which enhanced intra-chromosomal interaction of the genes, causing reduction of gene expression. Although the levels of chromatin interactions and gene transcriptional changes caused by overexpression of RAD21 were lower than those of MDA-MB-453 parental cells, we clearly found the reverse results in response to the loss of function-based study in epithelial cancer cell lines. Related statements and results have been added on Page 14 in the revised manuscript and in the revised Fig EV5D-G. 3. It is not clear to me how the two candidate genes TGFB1 and ITGA5 have been picked. The results in Fig. 3F and 3G suggest that RAD21 is controlling a wider spectrum of genes that regulate EMT! è We apologize for not making this clear in the original manuscript. To pick up the candidate genes-regulated by RAD21 knockdown that control the EMT state directly, we analyzed the topscored genes that showed greater than two-fold-changes in RAD21KD-MCM7 cells and those in SNU16 cells. We commonly found the two genes in the same functional annotation cluster, TGFB1 and ITGA5 in both the RAD21KD-MCM7 and -SNU16 set (revised Table EV3 and EV4). Consistent with the referee's comment, RAD21 KD appears to control many other genes related to EMT, such as CDH2 and TWIST as shown in the original Figure 2C . However, these genes were not among the top-scored genes in the microarray data. We have added functional annotation cluster analysis data to Figure 3F and 3G show the genes regulated by each TGFB1 and ITGA5 gene knockdown in RAD21KD-MCF7 or -SNU16 cells.
To confirm the function of RAD21 on the transcriptional regulation of TGFB1 and ITGA5 through modulating the transcriptionally repressive gene-specific chromatin architecture in epithelial cancer cells, we reversely overexpressed RAD21 in MDA-MB-231 mesenchymal breast cancer cell and MDA-MB-453 CSLC cell with a low level of RAD21 expression (Figs 6A-D and EV5D-F, respectively). Although the transient overexpression of RAD21 did not appear to be sufficient in
MDA-MB-231 and CSLC cells, we clearly found that the overexpressed RAD21 in mesenchymal cancer cells reduced TGFB1 and ITGA5 gene transcriptions (
It would be nice to combine siTGFB1 and siITGA5 in shR#1 cells to see if the effects can be synergistic. è We thank the referee for their helpful comment. We transiently knocked-down TGFB1 and ITGA5 together in RAD21KD-MCF7 and -SNU16 cells (each shR#1 clones) using 20 nM of siTGFB1#4 and siITGA5#1, respectively. Although we used the same dose of siRNAs (each 20 nM) as in the original figure 3F and G and each gene appeared to be sufficiently knocked-down, the results showed no significant synergism leading to changes in the expression of other EMT-related genes (Compared to Figure 3F -G). This may indicate that each genes was not sufficiently suppressed to show synergistic de-regulation of EMT-related genes. There was also a possibility that the down-regulated level of the EMT-related genes provides the minimum condition for cell survival in the RAD21KD-epithelial cancer cells. The related data are shown in Data only for referee Fig 3. 4. Fig. 2A: shows expression of which gene? I guess RAD21 è We apologize for our mistake. We have added the following sentence to the figure legend and marked "RAD21 expression" in the revised figure. "qPCR was performed to measure the expression of RAD21" 5. Fig. EV2B : The "0" hour time point is lacking. Maybe TGFB1 and ITGA5 are already deregulated within the first 12 hours upon RAD21 knockdown? è We apologize for this oversight. As the referee suggested, we have added the mRNA expression level at time "0" to the revised figure. In general for IF the cell density is very low to show membrane staining of the adhesion complex and decide whether b-cat is in the nucleus or not. This needs to be improved. è We apologize for providing IFA data with a low resolution and thank you for your helpful comment. First, although the IFA image in the original Fig. EV5A seemed to show that T47D cells didn't express E-cadherin on the cell membrane, we thought the results was due to the low density of the cells as the referee mentioned. Actually, we just want to visually show the relative overall expression level of the molecule compared to the control cells. Similar to our images, IFA images for E-cadherin in T47D cells have been shown in other studies [21, 22] . Based on our data, E-cadherin in MCF7 cells (shown in the original figure 1B) exist not only in the nucleus, but also the cytoplasm. And beta-catenin in the epithelial cancer cells is primarily observed in the cytoplasm. However, when RAD21 was knocked down, the beta-catenin seems to be in both the cytoplasm and the nucleus, suggesting that Wnt signaling might be activated under these conditions [23, 24] . The related IFA images have been enlarged and the image resolutions have been improved in the revised figures.
8. Overall I suggest some language editing, as I observed some grammar errors è The entire manuscript has been professionally edited by a native English speaker.
9. P. 9:, lines 5-7: switch terms "low" and "high" expression, as it is mixed up between epithelial and mesenchymal cell lines è We apologize for our mistake. We have revised the sentence in the revised manuscript as follows:
"we used mesenchymal breast cancer HCC1143 cells, which express high levels of both TGFB1 and ITGA5, and epithelial breast cancer MCF7 cells, in which TGFB1 and ITGA5 are expressed at low." 10. P.10: end of first paragraph: how can "transcription marks" be "recruited" to promoters as they represent histone modifications introduced by histone modifying enzymes? è We have replaced "recruitment" with "enrichment" in the revised manuscript. Thank you for the submission of your revised manuscript to our editorial offices. We have now received the enclosed reports on it. As you will see, all referees find the manuscript suitable for publication in EMBO reports. However, referee #1 has still several comments that need to be addressed. In particular, the raw Affymetrix array data should be deposited in GEO. Please also address the other referee comments in a detailed point-by-point response. I would therefore like to ask you for further minor revisions (see also below), before we can proceed with the formal acceptance of your manuscript.
The title is currently too long (128 characters with spaces -it should be not more than 100). Please shorten the title accordingly. Also the abstract has more than 175 words. Please also shorten this, please. The main text (including references) has more than 55000 words. It would be nice, if you could shorten also this to reach 55000, maybe by condensing the material and methods part (see also below).
Please also update the expanded view table legends, as you changed some of these to become datasets.
Important: All materials and methods should be included in the main manuscript file. Please move the material and methods from the appendix to the main manuscript.
Regarding data quantification and statistics, can you please specify the number "n" for how many experiments were performed, the bars and error bars (e.g. SEM, SD) and the test used to calculate pvalues in the respective figure legends? This information must be provided in the figure legends. I look forward to seeing a revised version of your manuscript when it is ready. Please let me know if you have questions or comments regarding the revision.
REFEREE REPORTS
Referee #1:
Version 2, Yun et al, Cohesin-mediated chromatin organization of TGFB1 and ITGA5 controls epithelialmesenchymal transition plasticity in cancer cells.
The authors have added a considerable amount of data to the manuscript, along with clarification of many points. The second version is very much improved. I still have a few concerns that should be addressed.
1. Regarding the authors' response to my point 4 about the Affymetrix array data. The array data in its raw form is still missing. These data should be deposited in GEO. Though tables are provided, it would still be good to show clustering analysis or heatmaps on the array data, methods of normalisation, etc (RMA?). Despite the correlation shown in 'For referee Fig 1E' , the comparison to other the array done was not appropriate, since similar experimental conditions were not compared. GSM1142895 was simply 'MCF-7 cells grown in normoxia for 90 hours'. Whereas the suggested GSE59908 was 'Expression data from MCF7 cells depleted of the cohesin subunit RAD21 and treated with estrogen or vehicle' (also Affymetrix, the same platform, contrary to the authors claims). It is possible to compare across array types in the same platform. 4. Regarding the authors' response to my point 11 about RAD21 expression, copy number and mesenchymal vs epithelial phenotype. The authors respond "Although the other subunits of cohesin complex SMC1A and STAG2 were also checked, there were no significant differences between the epithelial and mesenchymal breast cancer cell lines (Fig EV1A) ". From this, we conclude that other cohesin subunits are not behaving/influencing EMT as RAD21 does. Therefore, do the authors think that RAD21 is operating outside of the cohesin complex in EMT? Why would this subunit in particular be linked to EMT? Is it rate-limiting for cohesin complex formation and therefore EMT? Clarification here would be helpful.
5. Regarding the authors' response to my minor point 6 about providing closer views of cell morphology in Fig 3A. The authors have done this, but the result is unsatisfactory. The close-ups are out of focus, and it is even harder to interpret cell shape than in the main panels. Also, please align the panels properly to the figure margins.
6. Regarding the authors' response to my minor point 6 about using b-catenin localization to determine Wnt signaling status. The authors supply the following: "According to a recent study that showed TGFB activates canonical Wnt signaling, the results of this study suggested that the TGFB1 induced by RAD21KD might lead to the accumulation of β-catenin into the nucleus via the canonical Wnt signaling pathway, accelerating EMT-related gene activation." This is still speculative in the absence of hard evidence. The results showed that the EMT-related genes used in this study, including VIM, ZEB1, CDH2, SNAI2, and TWIST, were slightly up-regulated when TGFB1 and ITGA5 were depleted (See "Data only for referee Fig  1C" ). These results are similar to those observed for RAD21KD-MCF7 cells." This interpretation of the data supplied is not correct. According to Fig 1C, none of these genes are significantly upregulated (some are slightly downregulated). The expression also looks to be quite different in non-RAD21KD-MCF7 cells than in long-term RAD21-depleted cells (Fig 3F,G) We thank you and the reviewers for your consideration and comments regarding our manuscript entitled, "Cohesin-mediated chromatin organization of TGFB1 and ITGA5 controls epithelialmesenchymal transition plasticity in cancer cells" (EMBOR-2015-41852V2). In the meantime, we have tried to respond to several questions and comments from reviewer. Detailed responses are available in the 2 nd Rebuttal letter. As commented by the editor, the title and abstract have been shorten and the methods section of the manuscript has been shorten to adjust them into 55000 word limit.
We hope that you and the reviewer will find our efforts satisfactory. Again, we thank you and the reviewer for giving us the opportunity to respond to the comments. We hope that this revised manuscript would be acceptable for publication in the EMBO reports. Thank you for your consideration.
Referee #1:
Version 2, Yun et al, Cohesin-mediated chromatin organization of TGFB1 and ITGA5 controls epithelial mesenchymal transition plasticity in cancer cells.
1. Regarding the authors' response to my point 4 about the Affymetrix array data. The array data in its raw form is still missing. These data should be deposited in GEO. à As suggested by the referee, the array data has been deposited. GSE82049. The related sentence has been described in the 2 nd revised manuscript as follows:
On page 20 "These expression data have been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE82049."
Though tables are provided, it would still be good to show clustering analysis or heatmaps on the array data, methods of normalisation, etc (RMA?). à According to the referee's comment, we have provided heat maps for the array data (Fold change > 2) in "2 nd Data only for referee Fig 1" . The array was normalized using RMA methods of ExpressionConsole program provided by Affymetrix corp.
Despite the correlation shown in 'For referee Fig 1E' , the comparison to other the array done was not appropriate, since similar experimental conditions were not compared. GSM1142895 was simply 'MCF-7 cells grown in normoxia for 90 hours'. Whereas the suggested GSE59908 was 'Expression data from MCF7 cells depleted of the cohesin subunit RAD21 and treated with estrogen or vehicle' (also Affymetrix, the same platform, contrary to the authors claims). It is possible to compare across array types in the same platform. à According to the referee's comment, we have tried to compare our data with GSE59908 (GSM1453428, "MCF7_RAD21 siRNA_6 h") data, though, we couldn't because of different array platforms. While the platform of the data suggested by the referee #1 is [PrimeView] Affymetrix Human Gene Expression Array, our data is "affymetrix human gene st 2.0 platform". As the referee might be aware, it is difficult to compare and analyze those two data with different platforms in the same ExpressionConsole program due to the different probe contents. Besides, there were several differences between those two samples which made the comparison of the data difficult. Although the data from GSE59908 and our data commonly show the mRNA expression in RAD21-deprived MCF-7 cells, several factors were different: the knockdown conditions of RAD21 molecule (siRNAs versus shRNAs, knockdown times, etc.), cell culture conditions, and array analysis methods, etc. Tables EV1 and EV2 could potentially be rather biased -many of these genes are involved in other functional pathways as well, such as cell growth, survival (BCL2, IGF1R, IGFBP5, RRAS). Could the authors show the relative representation of motility pathways relative to all pathways that emerge via DAVID? Are the same genes regulated in other array datasets? à Thank you for the comment. According to the referee's suggestion, we performed functional annotation analysis (EASE score <0.05 and high classification stringency) of the genes-upregulated by RAD21KD-MCF7 cells with all pathways provided by DAVID tool. The functional annotation analysis included disease, functional categories (Ontology, Keywords, Features), gene ontology (BP, CC, MF), pathways (BBID, BIOCARTA, KEGG pathway) and protein domains. Consistent with the data shown in Expanded View Table EV3 , the data ("2nd Data only for referee Table 1 ") showed that most functional annotation clustering involved cell motions and migrations. As we cut off the enrichment score > 2.0 and EASE score < 0.05, the genes mentioned by the referee were not included in the selected functional annotation clustering.
The enrichments scores in Tables EV1 and EV2 are rather modest, with the maximum enrichment being 4. Most enrichment scores presented are only 2-3. In a similar enrichment pathway analysis, Antony et al Pubmed 25542856 [uid] showed enrichment scores >5. Have the EMT enrichment data been cherry-picked? à No. we did not cherry pick the EMT enrichment data. As we described in the manuscript, Tables  EV3 and EV4 show the functional annotation clustering analysis data using all 397 up-regulated genes (fold change > 2) by RAD21 depletion in MCF-7 cells. This data was analyzed with EASE score < 0.05 and high classification stringency. As mentioned above, most enrichment scores from maximum to minimum included cell motion and mobility-related clustering.
3. Figures 1 and 2 for referees only. Thank you for supplying these figures. The addition of legends would help in their interpretation. à As the referee recommended, in the revised Appendix_ Data only for reviewer, we have added the figure legends for "Data only for referees" in Appendix_Data only for reviewer_Figure legends as follows: 
4.
Regarding the authors' response to my point 11 about RAD21 expression, copy number and mesenchymal vs epithelial phenotype. The authors respond "Although the other subunits of cohesin complex SMC1A and STAG2 were also checked, there were no significant differences between the epithelial and mesenchymal breast cancer cell lines (Fig EV1A) ". From this, we conclude that other cohesin subunits are not behaving/influencing EMT as RAD21 does. Therefore, do the authors think that RAD21 is operating outside of the cohesin complex in EMT? Why would this subunit in particular be linked to EMT? Is it rate-limiting for cohesin complex formation and therefore EMT? Clarification here would be helpful.
à As we mentioned in the manuscript, we found that only RAD21 protein levels were different between epithelial and mesenchymal breast cancer cell lines. But in other subunits of cohesin complex, they were not. Therefore, we suspected that RAD21 was more crucial factor for regulating the level of overall cohesin complex, which is functionally perfect molecule, in cells than in other subunits. If the level of RAD21 was low, the cohesin complex would be formed not as much as when the level of that was high. Contrary to this, if RAD21 was high, much cohesin complex would be formed. Actually, this was proved by a ChIP assay, when RAD21 was knocked down, the binding of RAD21 on genes was reduced. Simultaneously, binding of the other subunit of cohesin complex, SMC1, on the genes was decreased as well. The related data has been added in "2nd Data only for referee Fig 2". 5. Regarding the authors' response to my minor point 6 about providing closer views of cell morphology in Fig 3A. The authors have done this, but the result is unsatisfactory. The close-ups are out of focus, and it is even harder to interpret cell shape than in the main panels. Also, please align the panels properly to the figure margins. à We agree that the referee #1's comment is reasonable. Although we have tried to get morphological cancer cell images with the greatest resolution, we couldn't have it as good as we wanted because of our microscopes with low resolutions. So, we are really sorry for this issue. And as the referee suggested, the panels have been aligned properly in the 2 nd revised figure.
6. Regarding the authors' response to my minor point 6 about using b-catenin localization to determine Wnt signaling status. The authors supply the following: "According to a recent study that showed TGFB activates canonical Wnt signaling, the results of this study suggested that the TGFB1 induced by RAD21KD might lead to the accumulation of β-catenin into the nucleus via the canonical Wnt signaling pathway, accelerating EMT-related gene activation." This is still speculative in the absence of hard evidence. à We are sorry for providing unclarified sentence in the manuscript. As described in the manuscript, we speculated that nucleus beta-catenin by RAD21-depletion was activated through canonical Wnt signaling pathway activation, accelerating EMT-related gene activation. This was based on many other studies on β-catenin-Wnt signaling pathway regarding to EMT [1, 2] . However, as mentioned by the referee, we have clarified and changed the sentence for this issue in the 2 nd revised manuscript as follows; The results showed that the EMT-related genes used in this study, including VIM, ZEB1, CDH2, SNAI2, and TWIST, were slightly up-regulated when TGFB1 and ITGA5 were depleted (See "Data only for referee Fig  1C" ). These results are similar to those observed for RAD21KD-MCF7 cells." This interpretation of the data supplied is not correct. According to Fig 1C, none of these genes are significantly upregulated (some are slightly downregulated). The expression also looks to be quite different in non-RAD21KD-MCF7 cells than in long-term RAD21-depleted cells (Fig 3F,G) , contrary to the author's claims. Is there an explanation for this? à We really apologize for providing confusing sentences in the previous rebuttal letter. "These results are similar to those observed for RAD21KD-MCF7 cells" means that the gene expression changes were similar to the patterns observed in siTGFB1 and siITGA5-treated RAD21KD-MCF7cells (shown in Fig 3F-G) .
8. Regarding the authors' response to referees 2 and 3, who both wanted to see RAD21 overexpression reverse the EMT phenotype. In my opinion, this is not an ideal experiment; at least, not if one believes RAD21 exerts its EMT effects by acting in the cohesin complex. Due to a requirement for 1:1 stoichiometry of cohesin subunits, overexpression of just one subunit (RAD21) is just as likely to compromise cohesin's activity as enhance it. à As mentioned above, we considered RAD21 as a late-limiting molecule for formation of cohesin complex. From a ChIP assay, when RAD21 was overexpressed in MDA-MB-231 cells which have low expression of RAD21, we observed that RAD21 binding on the TGFB1 gene was induced. At the same time, the binding of SMC1 molecule was also enriched on the gene ("2 nd Data only for referee Fig 3") , suggesting that the overexpression of RAD21 molecule assembled other subunits of cohesin complex to form the functional complex.
Furthermore, just as the authors experienced, (anecdotally) others also found that cells do not tolerate RAD21 overexpression well (it's apparently quite toxic). Nevertheless, it seemed like the authors achieved a modest long-term overexpression of RAD21. à As mentioned in the 1 st revised manuscript, overexpression of RAD21 occurred only for about 2 weeks. And we described in the first rebuttal letter, that cells (e.g. HCT1143) overexpressing RAD21 was not able to maintain their population during cell culture with unknown reasons. We thought that the reason for that would be due to RAD21 overexpression per se as the referee mentioned.
However, the data supporting overexpression are confusing. Why is overexpressed RAD21 in Fig  6B a different (much larger) size? (state the size). Is it tagged? What with? If so, would the tag affect its activity? Stability? à Yes, as described on page 19 in the material methods section of 1 st revised manuscript, the overexpressed RAD21 was the fusion protein with GFP-tagged. That's why the western blot for the overexpressed RAD21 appeared to be shifted compared to mock. As the referee may know and many studies have proved, GFP-tagged fusion protein is generally used for overexpression of exogenous protein. So, we believe that the GFP-tagged RAD21 would function normally. From ChIP assay for other cohesin subunit, SMC1, in the "2 nd Data only for referee Fig 3" , the data said that the overexpression of RAD21 functioned normally. Also, the normal RAD21 band appears to be upregulated in Fig 6B. What is the explanation for this? à We thought that the western band seemed to be more exposed than that shown in Fig 1A The term "reversely overexpressed" sounds strange: consider modifying. à We apologize for using an inappropriate term. As the referee suggested, we decided to remove "reversely" in the manuscript. The related sentence has been changed in the 2 nd revised manuscript as follows:
On page 14 "We overexpressed RAD21 in MDA-MB-231 mesenchymal breast cancer cell and MDA-MB-453…" 9. A further comment about statistical analyses. Throughout, the student's t-test was used, but in cases where all samples were normalized to a control of '1', to what values was the test applied? The fold-change over 1, or the original values? It would be best if the statistics were applied to the raw (rather than processed) values. This should be clarified in the manuscript. à Thank the referee for the comment. As mentioned in the manuscript, all samples including controls were normalized by reference genes such as 18S rRNA or Actin. And then each value was divided by the original values in controls. However, according to the referee's comment, we have moved the "Data only for referee Fig 1D" into "Expanded View Figure EV3D ".
10. Comment about referencing other studies showing that RAD21 knockdown enhances expression of selected genes, including increasing Pol II recruitment, as stated: "Consistent with our results, several studies have shown that knockdown of RAD21 leads to significant recruitment of Ser2-Pol2, causing the activation of gene transcription." Pubmed 25542856 [uid] showed this clearly and could be cited.
